Works matching DE "SANOFI-Aventis SA"
1
- Oncology (08909091), 2006, v. 20, n. 10, p. 1132
- Article
2
- Patient Care (Online), 2024, p. 1
- Article
3
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 7, p. 673, doi. 10.1111/j.1463-1326.2011.01421.x
- Article
4
- Expert Review of Clinical Pharmacology, 2010, v. 3, n. 6, p. 717
- Article
5
- Missouri Law Review, 2011, v. 76, n. 3, p. 645
- Article
6
- Expert Review of Endocrinology & Metabolism, 2010, v. 5, n. 6, p. 797
- Article
7
- Expert Review of Endocrinology & Metabolism, 2010, v. 5, n. 6, p. 797
- Article
8
- Australian Prescriber, 2012, v. 35, n. 6, p. 207, doi. 10.18773/austprescr.2012.088
- Article
9
- Research Technology Management, 1996, v. 39, n. 3, p. 36, doi. 10.1080/08956308.1996.11671062
- Article
11
- Clinical Infectious Diseases, 2008, v. 46, n. 9, p. iii
- Article
12
- Clinical Infectious Diseases, 2008, v. 46, n. 8, p. iv
- Article
13
- Clinical Infectious Diseases, 2007, v. 44, n. 12, p. iv
- Article
14
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- Article
15
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- Article
16
- Clinical Infectious Diseases, 2007, v. 44, n. 9, p. iii
- Article
17
- Clinical Infectious Diseases, 2007, v. 44, n. 4, p. iii
- Article
18
- Clinical Infectious Diseases, 2006, v. 42, n. 8, p. 2
- Article
19
- Clinical Infectious Diseases, 2005, v. 41, n. 3, p. 1
- Article
20
- Clinical Infectious Diseases, 2004, v. 39, n. 9, p. 1
- Article
24
- Australian Journal of Pharmacy, 2011, v. 92, n. 1097, p. 58
- Article
25
- Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 48
- Article
26
- AUANews, 2014, v. 19, n. 11, p. 1
- Article
27
- Contemporary Pediatrics, 2008, v. 25, n. 10, p. 19
- Article
28
- Brown University Psychopharmacology Update, 2005, v. 16, n. 11, p. 8
- Article
29
- Journal of Cardiovascular Pharmacology & Therapeutics, 2007, v. 12, n. 1, p. 15, doi. 10.1177/1074248406299069
- Tafreshi, Mohammad J.;
- Rowles, Joie
- Article
30
- Asia Pacific Journal of Clinical Oncology, 2012, v. 8, p. 7, doi. 10.1111/j.1743-7563.2012.01573_6.x
- Article
31
- Asia Pacific Journal of Clinical Oncology, 2012, v. 8, p. 35, doi. 10.1111/j.1743-7563.2012.01576.x
- Article
32
- Bulletin of the World Health Organization, 2009, v. 87, n. 8, p. 579, doi. 10.2471/BLT.09.060809
- Article
33
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 21, p. 2176, doi. 10.1001/jama.2015.5634
- Article
34
- Applied Clinical Trials, 2010, v. 19, n. 9, p. 28
- Article
35
- Applied Clinical Trials, 2006, v. 15, n. 1, p. 58
- Article
36
- Applied Clinical Trials, 2005, v. 14, n. 4, p. 18
- Article
37
- Journal of Diabetes, 2017, v. 9, n. 4, p. 320, doi. 10.1111/1753-0407.12524
- Marathe, Payal H.;
- Gao, Helen X.;
- Close, Kelly L.
- Article
38
- Journal of Diabetes, 2015, v. 7, n. 4, p. 437, doi. 10.1111/1753-0407.12290
- Article
39
- Journal of Diabetes, 2014, v. 6, n. 4, p. 274, doi. 10.1111/1753-0407.12145
- Article
40
- Clinical Infectious Diseases, 2016, v. 63, n. 7, p. ii, doi. 10.1093/cid/ciw503
- Article
41
- Clinical Infectious Diseases, 2011, v. 53, n. 2, p. 107, doi. 10.1093/cid/cir397
- Article
42
- Clinical Infectious Diseases, 2011, v. 52, n. 10, p. i, doi. 10.1093/cid/cir252
- Article
43
- Clinical Infectious Diseases, 2010, v. 51, n. 10, p. i, doi. 10.1086/657565
- Article
44
- Clinical Infectious Diseases, 2010, v. 50, n. 4, p. i
- Article
45
- Clinical Infectious Diseases, 2009, v. 49, n. 4, p. ii
- Article
46
- TCE: The Chemical Engineer, 2010, n. 833, p. 11
- Article
47
- TCE: The Chemical Engineer, 2010, n. 832, p. 8
- Article
48
- TCE: The Chemical Engineer, 2009, n. 819, p. 5
- Article
49
- TCE: The Chemical Engineer, 2008, n. 805, p. 5
- Article
50
- Nature Medicine, 2013, v. 19, n. 3, p. 256, doi. 10.1038/nm0313-256
- Article